Revitope Oncology

Revitope Oncology

Developing a novel approach to cancer immunotherapy. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
AUD62—93m (Dealroom.co estimates Dec 2020.)
Cambridge Massachusetts (HQ)
Authorizing premium user...